Molecular Insight Pharmaceuticals, Inc.Cambridge, MA, United States (NASDAQ (GM): MIPI)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Molecular Insight Income Statement

All amounts in millions of except per share amounts.
View: Annual
Dec 07 Dec 06 Dec 05
Revenue 0.7 0.3 1.2
Cost of Goods Sold -- 16.6 --
Gross Profit -- (16.3) --
Gross Profit Margin 0.0% 0.0% 0.0%
SG&A Expense 57.7 9.9 19.7
Depreciation & Amortization 0.7 0.3 0.1
Operating Income (57.7) (26.5) (18.6)
Operating Margin -- -- --
Nonoperating Income 2.6 0.5 0.5
Nonoperating Expenses 4.7 1.2 0.1
Income Before Taxes (59.8) (27.3) (18.3)
Income Taxes -- -- --
Net Income After Taxes (59.8) (27.3) (18.3)

Continuing Operations (59.8) (27.3) (18.3)
Discontinued Operations -- -- --
Total Operations (59.8) (27.3) (18.3)
Total Net Income (59.8) (27.3) (18.3)
Net Profit Margin -- -- --

Diluted EPS from Total Net Income ($) (2.65) (7.18) (5.30)
Dividends per Share -- -- --
Edgar Online logo
This data is provided as per license from EDGAR Online